ELOXX PHARMACEUTICALS INC (ELOX)
US29014R2022 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.33M | 19.21M | 42.27M | 24.67M | 22.49M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 33.78M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.05M | 922.00K | 1.21M | 1.23M | 1.43M | |||
| Total Current Assets | 5.38M | 20.13M | 43.48M | 25.89M | 57.71M | |||
| Non-Current Assets | ||||||||
| PPE Net | 611.00K | 994.00K | 1.66M | 550.00K | 1.13M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 30.00K | 110.00K | |||
| Total Non-Current Assets | 611.00K | 994.00K | 1.66M | 590.00K | 1.24M | |||
| TOTAL ASSETS | 5.99M | 21.12M | 45.14M | 26.48M | 58.95M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.28M | 3.98M | 0.00 | 5.24M | 4.34M | |||
| Accrued Expenses | 3.24M | 3.51M | 4.85M | 3.02M | 5.15M | |||
| Accounts Payable | 3.12M | 3.02M | 1.38M | 480.00K | 1.87M | |||
| Other Current Liabilities | 12.61M | 12.58M | 3.72M | 1.10M | 450.00K | |||
| Total Current Liabilities | 21.25M | 23.09M | 9.96M | 9.84M | 11.81M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.33M | 8.56M | 12.00M | 6.38M | 10.50M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.00K | 135.00K | 804.00K | 30.00K | 430.00K | |||
| Total Non-Current Liabilities | 3.34M | 8.69M | 12.80M | 6.41M | 10.92M | |||
| TOTAL LIABILITIES | 24.59M | 31.78M | 22.75M | 16.25M | 22.73M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -284.96M | -274.39M | -238.32M | -171.60M | -137.02M | |||
| Additional Paid In Capital | 266.38M | 263.71M | 262.03M | 183.25M | 174.52M | |||
| Common Shares | 25.00K | 22.00K | 871.00K | 400.00K | 400.00K | |||
| Treasury Stock | N/A | 0.00 | -2.19M | -1.83M | -1.70M | |||
| Other Shareholders' Equity | -41.00K | N/A | N/A | N/A | 20.00K | |||
| Shares Outstanding | 2.49M | 2.17M | 2.17M | 40.16M | 40.03M | |||
| Tangible Book Value per Share | -7.46 | -4.92 | 10.33 | 0.25 | 0.90 | |||
| Total Shareholders' Equity | -18.60M | -10.66M | 22.38M | 10.23M | 36.21M | |||
| TOTAL LIABILITIES AND EQUITY | 5.99M | 21.12M | 45.14M | 26.48M | 58.95M | |||
| Statistics | ||||||||
| Debt/Equity | -0.18 | -0.80 | 0.54 | 0.62 | 0.29 | |||
| Current Ratio | 0.25 | 0.87 | 4.37 | 2.63 | 4.89 | |||
| Return On Assets (ROA) | -407.11% | -170.74% | -147.83% | -130.59% | -86.29% | |||
| Return On Equity (ROE) | N/A | N/A | -298.10% | -338.03% | -140.49% | |||
All data in USD